Dimensional Fund Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Dimensional Fund Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$6.85M	Sell	45,333 -46,030	-50%	-$6.82M	﹤0.01%	2310
2022 Q2	$13.3M	Buy	91,363 +8,764	+11%	+$1.12M	﹤0.01%	2080
2022 Q1	$9.79M	Buy	82,599 +29,413	+55%	+$3.67M	﹤0.01%	2304
2021 Q4	$7.33M	Sell	53,186 -20,990	-28%	-$2.67M	﹤0.01%	2426
2021 Q3	$10.3M	Buy	74,176 +57,543	+346%	+$7.18M	﹤0.01%	2316
2021 Q2	$1.61M	Buy	16,633 +8	+0%	+$649	﹤0.01%	2929
2021 Q1	$1.14M	Sell	16,625 -10,335	-38%	-$836K	﹤0.01%	2987
2020 Q4	$2.31M	Sell	26,960 -2,648	-9%	-$224K	﹤0.01%	2768
2020 Q3	$1.93M	Buy	+29,608	New	+$1.94M	﹤0.01%	2758

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

SFM

Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dimensional Fund Advisors's BHVN Position: Q3 2022 in Review

Dimensional Fund Advisors reduced its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 50% in Q3 2022, selling an estimated $6.82M and leaving 45,333 shares worth $6.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2310.

Dimensional Fund Advisors first reported a position in BHVN in Q3 2020 and has held it in 9 quarters since. The position peaked at $13.3M in Q2 2022. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

Dimensional Fund Advisors held 45,333 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $6.85M as of Q3 2022.
Dimensional Fund Advisors sold 46,030 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $6.82M.
Biohaven Pharmaceutical Holding Company Ltd. made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #2310 holding.
Dimensional Fund Advisors first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2020 and has held it in 9 quarters since.
Dimensional Fund Advisors's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $13.3M in Q2 2022.
240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.